Skip to main content

Animations

MJFF Publications

6081 - 6090 of 6515 Results
Title
Year
  • Year
  • 2018
  • 2023
  • 2023
  • 2022
  • 2019
  • 2021
  • 2015
  • 2023
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.644
    Citation Count: 655
  • Summary Details
    OPEN
    Title: Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI study
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2023.106343
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Interaction of an α-synuclein epitope with HLA-DRB1∗15:01 triggers enteric features in mice reminiscent of prodromal Parkinson’s disease
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.neuron.2023.07.015
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Plasma MIA , CRP , and Albumin Predict Cognitive Decline in Parkinson's Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.26410
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Development of a Disease Progression Model for Leucine‐Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial Designs
    Journal Name: Clinical Pharmacology & Therapeutics
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/cpt.1634
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Dementia with Lewy bodies research consortia: A global perspective from the ISTAART Lewy Body Dementias Professional Interest Area working group
    Journal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1002/dad2.12235
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Aberrant cerebral network topology and mild cognitive impairment in early Parkinson's disease
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/hbm.22822
    Citation Count: 121
  • Summary Details
    OPEN
    Title: Inhibition of striatal dopamine release by the L‐type calcium channel inhibitor isradipine co‐varies with risk factors for Parkinson's
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1111/ejn.16180
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Rational design of structure‐based vaccines targeting misfolded alpha‐synuclein conformers of Parkinson's disease and related disorders
    Journal Name: Bioengineering & Translational Medicine
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/btm2.10665
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Genetic Modifiers of LRRK2 Parkinson's Disease: A Replication Study in Arab‐Berbers
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29735
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.